ArticleBMC cancer2022

Clinical application of artificial neural network (ANN) modeling to predict BRCA1/2 germline deleterious variants in Chinese bilateral primary breast cancer patients.

Yan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.